Polygenic risk for major depression, attention deficit hyperactivity disorder, neuroticism, and schizophrenia are correlated with experience of intimate partner violence

被引:0
|
作者
Andrew Ratanatharathorn
Luwei Quan
Karestan C. Koenen
Lori B. Chibnik
Marc G. Weisskopf
Natalie Slopen
Andrea L. Roberts
机构
[1] Columbia University Mailman School of Public Health,Department of Epidemiology
[2] Harvard T.H. Chan School of Public Health,Department of Epidemiology
[3] Harvard T.H. Chan School of Public Health,Department of Environmental Health
[4] Harvard T.H. Chan School of Public Health,Department of Social and Behavioral Sciences
[5] Broad Institute of MIT and Harvard,Department of Psychiatry
[6] Massachusetts General Hospital,Department of Neurology
[7] Massachusetts General Hospital,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Research has suggested that mental illness may be a risk factor for, as well as a sequela of, experiencing intimate partner violence (IPV). The association between IPV and mental illness may also be due in part to gene-environment correlations. Using polygenic risk scores for six psychiatric disorders - attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), bipolar disorder (BPD), major depressive disorder (MDD), neuroticism, and schizophrenia—and a combined measure of overall genetic risk for mental illness, we tested whether women’s genetic risk for mental illness was associated with the experience of three types of intimate partner violence. In this cohort of women of European ancestry (N = 11,095), participants in the highest quintile of genetic risk for ADHD (OR range: 1.38–1.49), MDD (OR range: 1.28–1.43), neuroticism (OR range: (1.18–1.25), schizophrenia (OR range: 1.30–1.34), and overall genetic risk (OR range: 1.30–1.41) were at higher risk for experiencing more severe emotional and physical abuse, and, except schizophrenia, more severe sexual abuse, as well as more types of abuse and chronic abuse. In addition, participants in the highest quintile of genetic risk for neuroticism (OR = 1.43 95% CI: 1.18, 1.72), schizophrenia (OR = 1.33 95% CI: 1.10, 1.62), and the overall genetic risk (OR = 1.40 95% CI: 1.15, 1.71) were at higher risk for experiencing intimate partner intimidation and control. Participants in the highest quintile of genetic risk for ADHD, ASD, MDD, schizophrenia, and overall genetic risk, compared to the lowest quintile, were at increased risk for experiencing harassment from a partner (OR range: 1.22–1.92). No associations were found between genetic risk for BPD with IPV. A better understanding of the salience of the multiple possible pathways linking genetic risk for mental illness with risk for IPV may aid in preventing IPV victimization or re-victimization.
引用
收藏
相关论文
共 50 条
  • [21] Risk of bipolar disorder and schizophrenia in relatives of people with attention-deficit hyperactivity disorder
    Larsson, Henrik
    Ryden, Eleonore
    Boman, Marcus
    Langstrom, Niklas
    Lichtenstein, Paul
    Landen, Mikael
    BRITISH JOURNAL OF PSYCHIATRY, 2013, 203 (02) : 103 - 106
  • [22] TRANSCRIPTOMIC RISK SCORES COMPLEMENT POLYGENIC RISK SCORES TO IMPROVE PREDICTION FOR ATTENTION DEFICIT/HYPERACTIVITY DISORDER
    Cabana-Dominguez, Judit
    Llonga, Natalia
    Arribas, Lorena
    Alemany, Silvia
    Vilar-Ribo, Laura
    Demontis, Ditte
    Fadeuilhe, Christian
    Corrales, Montse
    Richarte, Vanesa
    Ramos-Quiroga, Josep Antoni
    Soler Artigas, Maria
    Ribases, Marta
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2022, 63 : E99 - E100
  • [23] Impact of the polygenic risk scores for attention-deficit/hyperactivity disorder in Alzheimer's disease
    Leffa, Douglas T.
    Povala, Guilherme
    Bellaver, Bruna
    Ferrari-Souza, Joao Pedro
    Ferreira, Pamela C. L.
    Lussier, Firoza Z.
    Aguzzoli, Cristiano Schaffer
    Soares, Carolina
    Zalzale, Hussein
    Rohden, Francieli
    Bauer-Negrini, Guilherme
    Abbas, Sarah
    Schneider, Maite
    Therriault, Joseph
    Lopez, Oscar L.
    Villemagne, Victor L.
    Klunk, William E.
    Tudorascu, Dana L.
    Cohen, Ann D.
    Rosa-Neto, Pedro
    Zimmer, Eduardo R.
    Karikari, Thomas K.
    Rohde, Luis Augusto
    Molina, Brooke S. G.
    Pascoal, Tharick A.
    ALZHEIMERS & DEMENTIA, 2025, 21 (02)
  • [24] Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression
    Bangs, Mark E.
    Emslie, Graham J.
    Spencer, Thomas J.
    Ramsey, Janet L.
    Carlson, Christopher
    Bartky, Eric J.
    Busner, Joan
    Duesenberg, David A.
    Harshawat, Paras
    Kaplan, Stuart L.
    Quintana, Humberto
    Allen, Albert J.
    Sumner, Calvin R.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (04) : 407 - 419
  • [25] Association of Polygenic Liabilities for Major Depression, Bipolar Disorder, and Schizophrenia With Risk for Depression in the Danish Population
    Musliner, Katherine L.
    Mortensen, Preben B.
    McGrath, John J.
    Suppli, Nis P.
    Hougaard, David M.
    Bybjerg-Grauholm, Jonas
    Baekvad-Hansen, Marie
    Andreassen, Ole
    Pedersen, Carsten B.
    Pedersen, Marianne G.
    Mors, Ole
    Nordentoft, Merete
    Borglum, Anders D.
    Werge, Thomas
    Agerbo, Esben
    Stahl, Eli A.
    Breen, Gerome
    Forstner, Andreas J.
    McQuillin, Andrew
    Ripke, Stephan
    Trubetskoy, Vassily
    Mattheisen, Manuel
    Wang, Yunpeng
    Coleman, Jonathan R., I
    Gaspar, Helena A.
    de Leeuw, Christiaan A.
    Steinberg, Stacy
    Pavlides, Jennifer M. Whitehead
    Trzaskowski, Maciej
    Pers, Tune H.
    Holmans, Peter A.
    Abbott, Liam
    Agerbo, Esben
    Akil, Huda
    Albani, Diego
    Alliey-Rodriguez, Ney
    Als, Thomas D.
    Anjorin, Adebayo
    Antilla, Verneri
    Awasthi, Swapnil
    Badner, Judith A.
    Etzekvad-Hansen, Marie
    Barchas, Jack D.
    Bass, Nicholas
    Bauer, Michael
    Belliveau, Richard
    Bergen, Sarah E.
    Pedersen, Carsten Bocker
    Boen, Erlend
    Boks, Marco
    JAMA PSYCHIATRY, 2019, 76 (05) : 516 - 525
  • [26] Associations of polygenic risk scores differentiating attention-deficit hyperactivity disorder from autism spectrum disorder with cognitive and cortical alterations in Schizophrenia patients
    Kuramitsu, Ayumi
    Ohi, Kazutaka
    Shioiri, Toshiki
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2025, 34 (03) : 1149 - 1159
  • [27] A CAUSAL ROLE FOR ATTENTION DEFICIT/ HYPERACTIVITY DISORDER ON RISK-TAKING BEHAVIOURS, ACADEMIC AND FINANCIAL PROBLEMS AND MAJOR DEPRESSION
    Soler Artigas, Maria
    Sanchez-Mora, Cristina
    Rovira, Paula
    Vilar-Ribo, Laura
    Antoni Ramos-Quiroga, Josep
    Ribases, Marta
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 51 : E195 - E196
  • [28] Attention-Deficit/Hyperactivity Disorder and Suicidal Risk in Major Depression: Analysis of 141,530 Adolescent Hospitalizations
    Zahid, Shaheer
    Bodicherla, Krishna Priya
    Eskander, Noha
    Patel, Rikinkumar S.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (05)
  • [29] Joint contribution of polygenic scores for depression and attention-deficit/hyperactivity disorder to youth suicidal ideation and attempt
    Orri, Massimiliano
    Morneau-Vaillancourt, Genevieve
    Ouellet-Morin, Isabelle
    Cortese, Samuele
    Galera, Cedric
    Voronin, Ivan
    Vitaro, Frank
    Brendgen, Mara R.
    Dionne, Ginette
    Paquin, Stephane
    Forte, Alberto
    Turecki, Gustavo
    Tremblay, Richard E.
    Cote, Sylvana M.
    Geoffroy, Marie-Claude
    Boivin, Michel
    MOLECULAR PSYCHIATRY, 2025,
  • [30] Polygenic risk score analysis revealed shared genetic background in attention deficit hyperactivity disorder and narcolepsy
    Takahashi, Nagahide
    Nishimura, Tomoko
    Harada, Taeko
    Okumura, Akemi
    Choi, Damee
    Iwabuchi, Toshiki
    Kuwabara, Hitoshi
    Takagai, Shu
    Nomura, Yoko
    Newcorn, Jeffrey. H.
    Takei, Nori
    Tsuchiya, Kenji J.
    TRANSLATIONAL PSYCHIATRY, 2020, 10 (01)